The antibiotic road to poverty
Think you pay too much for prescription drugs? An interesting study released today in PLoS Medicine, an online journal, offers a bit of global perspective: For tens of millions of people around the world, buying a basic drug like the antibiotic amoxicillin is a road straight to poverty. The authors of the report took the ...
Think you pay too much for prescription drugs? An interesting study released today in PLoS Medicine, an online journal, offers a bit of global perspective: For tens of millions of people around the world, buying a basic drug like the antibiotic amoxicillin is a road straight to poverty.
The authors of the report took the cost of four basic drugs used to treat fairly ordinary conditions -- diabetes, high blood pressure, asthma, and bacterial infection. Using pricing information from 16 lower- and middle-income countries, they calculated how poverty rates would rise after patients purchased the drugs. The results, while not terribly surprising, do provide a blockbuster portrayal of what we've long known anecdotally. Buying brand name amoxicillin, for example, would push an additional 34 percent of Uganda's population into poverty levels of less than $1.25 a day. Even middle-income Indonesia would see an additional 39 percent of its population become poor from purchasing the drugs.
What's to be done? One answer has been the creation of consortiums to donate and subsidize the purchase of drugs, but that system isn't without drawbacks either. Another forthcoming study, one of whose authors is FP contributor Roger Bate, finds that corruption in the donated drug industry sees a solid percentage (6.5 percent in the study) of the anti-malarials sold off onto the market, rather than going to the government clinics where they were sent.
Think you pay too much for prescription drugs? An interesting study released today in PLoS Medicine, an online journal, offers a bit of global perspective: For tens of millions of people around the world, buying a basic drug like the antibiotic amoxicillin is a road straight to poverty.
The authors of the report took the cost of four basic drugs used to treat fairly ordinary conditions — diabetes, high blood pressure, asthma, and bacterial infection. Using pricing information from 16 lower- and middle-income countries, they calculated how poverty rates would rise after patients purchased the drugs. The results, while not terribly surprising, do provide a blockbuster portrayal of what we’ve long known anecdotally. Buying brand name amoxicillin, for example, would push an additional 34 percent of Uganda’s population into poverty levels of less than $1.25 a day. Even middle-income Indonesia would see an additional 39 percent of its population become poor from purchasing the drugs.
What’s to be done? One answer has been the creation of consortiums to donate and subsidize the purchase of drugs, but that system isn’t without drawbacks either. Another forthcoming study, one of whose authors is FP contributor Roger Bate, finds that corruption in the donated drug industry sees a solid percentage (6.5 percent in the study) of the anti-malarials sold off onto the market, rather than going to the government clinics where they were sent.
Of course in many ways, these studies are two sides of the same coin. Medicines are too expensive for their consumers in many a country — and hence, the profit from selling them is (in relative terms) enough to entice people to put their medicine up on the black market. Want one more externality? Fake drugs. Patients in desperate need of a pill are susceptible to the temptation of a cheaper version — even if it’s not guaranteed to be real.
Elizabeth Dickinson is International Crisis Group’s senior analyst for Colombia.
More from Foreign Policy
Lessons for the Next War
Twelve experts weigh in on how to prevent, deter, and—if necessary—fight the next conflict.
It’s High Time to Prepare for Russia’s Collapse
Not planning for the possibility of disintegration betrays a dangerous lack of imagination.
Turkey Is Sending Cold War-Era Cluster Bombs to Ukraine
The artillery-fired cluster munitions could be lethal to Russian troops—and Ukrainian civilians.
Congrats, You’re a Member of Congress. Now Listen Up.
Some brief foreign-policy advice for the newest members of the U.S. legislature.
Sign up for Morning Brief
Foreign Policy’s flagship daily newsletter with what’s coming up around the world today. Delivered weekdays.
By submitting your email, you agree to the Privacy Policy and Terms of Use and to receive email correspondence from us. You may opt out at any time.
